The Group has become a large-scale backbone enterprise of China's pharmaceutical business, operating more than 20,000 varieties of four categories of commodities: drugs, medical devices, chemical reagents and glass instruments, and maintaining good purchasing and sales relations with more than 400 medical stations and Hong Kong, Macao, Japan, the United States and Europe. Since its inception, the group has 42 consecutive years of profitable business performance, is China's important pharmaceutical procurement and supply center in East China.
The company invested 1 million yuan in April 1994 to purchase special equipment to establish a laboratory, set up a high-tech enterprises specializing in research and development of new products - Nanjing Life Energy Science and Technology Development Company, which has become the company's scientific research base. Since the establishment of the company, according to the requirements of the modern enterprise system, the construction of the enterprise business model, so that the company from the initial development of commercial enterprises into science, industry and trade as one of the enterprise groups.